ArticleScience advances2025
Excitation of Tamm plasmon polariton in ultrathin metals.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tamm Plasmon Resonance Responsiveness to SARS-CoV-2 Virus-Like Particles.Nanophotonics (Berlin, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tamm plasmon polariton (TPP) has unique localization and manipulability but cannot be excited with ultrathin metal films. We propose a strategy to realize generalized TPP (GTPP) in an ultrathin metal film as metainterface by introducing a low-loss dielectric Bragg reflector compensation layer, enabling effectively excitation of GTPP at its interface and achieving near-perfect absorption (~99.1%) at the resonant wavelength of 532 nanometers. This excitation has topological robustness, which fundamentally stems from its intrinsic tolerance to fabrication imperfections. A 14-channel narrowband absorbers chip based on GTPP has been fabricated. Compared to conventional structures without GTPP excitation, this device can lower the reverse saturable absorption threshold (~7.7 × 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.